$CBIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CATALYST BIOSCIENCES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in CATALYST BIOSCIENCES, INC.. Get notifications about new insider transactions in CATALYST BIOSCIENCES, INC. for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 8 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 21 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 26.08 | 2,100 | 54,765 | 1,153 | 3.3 K to 1.2 K (-64.56 %) |
Dec 21 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 1.75 | 2,100 | 3,675 | 3,253 | 1.2 K to 3.3 K (+182.13 %) |
Dec 20 2010 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Option Exercise | M | 8.51 | 2,700 | 22,977 | 18,390 | |
Dec 20 2010 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Sell | S | 25.24 | 2,700 | 68,142 | 1,159 | 3.9 K to 1.2 K (-69.97 %) |
Dec 20 2010 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Buy | M | 8.51 | 2,700 | 22,977 | 3,859 | 1.2 K to 3.9 K (+232.96 %) |
Dec 14 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | M | 1.75 | 12,000 | 21,000 | 0 | |
Dec 14 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Sell | S | 23.95 | 12,000 | 287,377 | 7,735 | 19.7 K to 7.7 K (-60.81 %) |
Dec 14 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Buy | M | 1.75 | 12,000 | 21,000 | 19,735 | 7.7 K to 19.7 K (+155.14 %) |
Dec 20 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 200 | 350 | 4,200 | |
Dec 20 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 25.15 | 200 | 5,030 | 1,153 | 1.4 K to 1.2 K (-14.78 %) |
Dec 20 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 1.75 | 200 | 350 | 1,353 | 1.2 K to 1.4 K (+17.35 %) |
Dec 14 2010 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | SVP - Bus. & Commer ... | Option Exercise | M | 2.93 | 10,000 | 29,300 | 32,658 | |
Dec 14 2010 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | SVP - Bus. & Commer ... | Sell | S | 23.86 | 10,000 | 238,553 | 0 | 10 K to 0 (-100.00 %) |
Dec 14 2010 | CBIO | CATALYST BIOSCIENC ... | Brennan Jeffrey P | SVP - Bus. & Commer ... | Buy | M | 2.93 | 10,000 | 29,300 | 10,000 | 0 to 10 K |
Dec 10 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 5.10 | 4,896 | 24,970 | 0 | |
Dec 10 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 5.10 | 6,354 | 32,405 | 0 | |
Dec 10 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 22.68 | 11,250 | 255,150 | 1,153 | 12.4 K to 1.2 K (-90.70 %) |
Dec 10 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 5.10 | 11,250 | 57,375 | 12,403 | 1.2 K to 12.4 K (+975.72 %) |
Dec 14 2010 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | SVP, Preclinical Re ... | Option Exercise | M | 2.93 | 10,624 | 31,128 | 23,908 | |
Dec 14 2010 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | SVP, Preclinical Re ... | Option Exercise | M | 8.51 | 14,275 | 121,480 | 14,280 | |
Dec 14 2010 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | SVP, Preclinical Re ... | Option Exercise | M | 5.55 | 7,194 | 39,927 | 30,751 | |
Dec 14 2010 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | SVP, Preclinical Re ... | Sell | S | 24.05 | 32,093 | 771,955 | 0 | 32.1 K to 0 (-100.00 %) |
Dec 14 2010 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | SVP, Preclinical Re ... | Buy | M | 2.93 | 10,624 | 31,128 | 32,093 | 21.5 K to 32.1 K (+49.49 %) |
Dec 14 2010 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | SVP, Preclinical Re ... | Buy | M | 8.51 | 14,275 | 121,480 | 21,469 | 7.2 K to 21.5 K (+198.43 %) |
Dec 14 2010 | CBIO | CATALYST BIOSCIENC ... | Bencherif Merouane | SVP, Preclinical Re ... | Buy | M | 5.55 | 7,194 | 39,927 | 7,194 | 0 to 7.2 K |
Nov 18 2010 | CBIO | CATALYST BIOSCIENC ... | SKALETSKY MARK B | Director | Option Exercise | M | 9.37 | 20,000 | 187,400 | 0 | |
Nov 18 2010 | CBIO | CATALYST BIOSCIENC ... | SKALETSKY MARK B | Director | Option Exercise | M | 2.71 | 9,500 | 25,745 | 0 | |
Nov 18 2010 | CBIO | CATALYST BIOSCIENC ... | SKALETSKY MARK B | Director | Option Exercise | M | 2.71 | 3,000 | 8,130 | 9,500 | |
Nov 18 2010 | CBIO | CATALYST BIOSCIENC ... | SKALETSKY MARK B | Director | Sell | S | 22.00 | 29,500 | 649,000 | 11,332 | 40.8 K to 11.3 K (-72.25 %) |
Nov 18 2010 | CBIO | CATALYST BIOSCIENC ... | SKALETSKY MARK B | Director | Buy | M | 9.37 | 20,000 | 187,400 | 40,832 | 20.8 K to 40.8 K (+96.01 %) |
Nov 18 2010 | CBIO | CATALYST BIOSCIENC ... | SKALETSKY MARK B | Director | Buy | M | 2.71 | 9,500 | 25,745 | 20,832 | 11.3 K to 20.8 K (+83.83 %) |
Nov 18 2010 | CBIO | CATALYST BIOSCIENC ... | SKALETSKY MARK B | Director | Sell | S | 21.76 | 3,000 | 65,295 | 11,332 | 14.3 K to 11.3 K (-20.93 %) |
Nov 18 2010 | CBIO | CATALYST BIOSCIENC ... | SKALETSKY MARK B | Director | Buy | M | 2.71 | 3,000 | 8,130 | 14,332 | 11.3 K to 14.3 K (+26.47 %) |
Nov 18 2010 | CBIO | CATALYST BIOSCIENC ... | BLIXT CHARLES A | Director | Option Exercise | M | 9.27 | 5,500 | 50,985 | 0 | |
Nov 18 2010 | CBIO | CATALYST BIOSCIENC ... | BLIXT CHARLES A | Director | Option Exercise | M | 9.27 | 2,000 | 18,540 | 5,500 | |
Nov 18 2010 | CBIO | CATALYST BIOSCIENC ... | BLIXT CHARLES A | Director | Option Exercise | M | 7.10 | 7,500 | 53,250 | 0 | |
Nov 18 2010 | CBIO | CATALYST BIOSCIENC ... | BLIXT CHARLES A | Director | Sell | S | 21.76 | 5,500 | 119,666 | 0 | 5.5 K to 0 (-100.00 %) |
Nov 18 2010 | CBIO | CATALYST BIOSCIENC ... | BLIXT CHARLES A | Director | Buy | M | 9.27 | 5,500 | 50,985 | 5,500 | 0 to 5.5 K |
Nov 18 2010 | CBIO | CATALYST BIOSCIENC ... | BLIXT CHARLES A | Director | Sell | S | 21.80 | 9,500 | 207,067 | 0 | 9.5 K to 0 (-100.00 %) |
Nov 18 2010 | CBIO | CATALYST BIOSCIENC ... | BLIXT CHARLES A | Director | Buy | M | 9.27 | 2,000 | 18,540 | 9,500 | 7.5 K to 9.5 K (+26.67 %) |
Nov 18 2010 | CBIO | CATALYST BIOSCIENC ... | BLIXT CHARLES A | Director | Buy | M | 7.10 | 7,500 | 53,250 | 7,500 | 0 to 7.5 K |
Nov 09 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 700 | 1,225 | 4,400 | |
Nov 09 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 25.02 | 700 | 17,512 | 1,153 | 1.9 K to 1.2 K (-37.78 %) |
Nov 09 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 1.75 | 700 | 1,225 | 1,853 | 1.2 K to 1.9 K (+60.71 %) |
Nov 09 2010 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Option Exercise | M | 8.51 | 1,400 | 11,914 | 21,090 | |
Nov 09 2010 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Sell | S | 25.01 | 1,400 | 35,014 | 1,159 | 2.6 K to 1.2 K (-54.71 %) |
Nov 09 2010 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Buy | M | 8.51 | 1,400 | 11,914 | 2,559 | 1.2 K to 2.6 K (+120.79 %) |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 150 | 263 | 5,100 | |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 1,271 | 2,224 | 0 | |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 6,363 | 11,135 | 0 | |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 986 | 1,726 | 6,363 | |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 25.07 | 7,784 | 195,139 | 1,153 | 8.9 K to 1.2 K (-87.10 %) |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 1.75 | 7,784 | 13,622 | 8,937 | 1.2 K to 8.9 K (+675.11 %) |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 25.05 | 986 | 24,699 | 1,153 | 2.1 K to 1.2 K (-46.10 %) |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 1.75 | 986 | 1,726 | 2,139 | 1.2 K to 2.1 K (+85.52 %) |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Option Exercise | M | 8.51 | 7,800 | 66,378 | 22,490 | |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Option Exercise | M | 8.51 | 1,000 | 8,510 | 30,290 | |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Sell | S | 25.08 | 7,800 | 195,605 | 1,159 | 9 K to 1.2 K (-87.06 %) |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Buy | M | 8.51 | 7,800 | 66,378 | 8,959 | 1.2 K to 9 K (+672.99 %) |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Sell | S | 25.06 | 1,000 | 25,055 | 1,159 | 2.2 K to 1.2 K (-46.32 %) |
Nov 05 2010 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Fin + Corp Sys & ... | Buy | M | 8.51 | 1,000 | 8,510 | 2,159 | 1.2 K to 2.2 K (+86.28 %) |
Oct 26 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Option Exercise | M | 2.93 | 8,500 | 24,905 | 39,594 | |
Oct 26 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Option Exercise | M | 2.93 | 600 | 1,758 | 48,094 | |
Oct 26 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Sell | S | 24.69 | 8,500 | 209,892 | 2,799 | 11.3 K to 2.8 K (-75.23 %) |
Oct 26 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Buy | M | 2.93 | 8,500 | 24,905 | 11,299 | 2.8 K to 11.3 K (+303.68 %) |
Oct 26 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Sell | S | 24.60 | 600 | 14,760 | 2,799 | 3.4 K to 2.8 K (-17.65 %) |
Oct 26 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Buy | M | 2.93 | 600 | 1,758 | 3,399 | 2.8 K to 3.4 K (+21.44 %) |
Oct 28 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Option Exercise | M | 2.93 | 1,500 | 4,395 | 36,094 | |
Oct 28 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Option Exercise | M | 2.93 | 2,000 | 5,860 | 37,594 | |
Oct 28 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Sell | S | 24.60 | 1,500 | 36,900 | 2,799 | 4.3 K to 2.8 K (-34.89 %) |
Oct 28 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Buy | M | 2.93 | 1,500 | 4,395 | 4,299 | 2.8 K to 4.3 K (+53.59 %) |
Oct 28 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Sell | S | 24.65 | 2,000 | 49,295 | 2,799 | 4.8 K to 2.8 K (-41.68 %) |
Oct 28 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Buy | M | 2.93 | 2,000 | 5,860 | 4,799 | 2.8 K to 4.8 K (+71.45 %) |
Jul 27 2010 | CBIO | CATALYST BIOSCIENC ... | DUNTON ALAN W | Director | Option Exercise | M | 5.69 | 2,864 | 16,296 | 13,000 | |
Jul 27 2010 | CBIO | CATALYST BIOSCIENC ... | DUNTON ALAN W | Director | Option Exercise | M | 5.69 | 2,336 | 13,292 | 15,864 | |
Jul 27 2010 | CBIO | CATALYST BIOSCIENC ... | DUNTON ALAN W | Director | Sell | S | 21.12 | 2,864 | 60,476 | 0 | 2.9 K to 0 (-100.00 %) |
Jul 27 2010 | CBIO | CATALYST BIOSCIENC ... | DUNTON ALAN W | Director | Buy | M | 5.69 | 2,864 | 16,296 | 2,864 | 0 to 2.9 K |
Jul 27 2010 | CBIO | CATALYST BIOSCIENC ... | DUNTON ALAN W | Director | Sell | S | 21.00 | 2,336 | 49,063 | 0 | 2.3 K to 0 (-100.00 %) |
Jul 27 2010 | CBIO | CATALYST BIOSCIENC ... | DUNTON ALAN W | Director | Buy | M | 5.69 | 2,336 | 13,292 | 2,336 | 0 to 2.3 K |
Jul 19 2010 | CBIO | CATALYST BIOSCIENC ... | DUNTON ALAN W | Director | Option Exercise | M | 5.69 | 6,800 | 38,692 | 18,200 | |
Jul 19 2010 | CBIO | CATALYST BIOSCIENC ... | DUNTON ALAN W | Director | Sell | S | 20.72 | 6,800 | 140,911 | 0 | 6.8 K to 0 (-100.00 %) |
Jul 19 2010 | CBIO | CATALYST BIOSCIENC ... | DUNTON ALAN W | Director | Buy | M | 5.69 | 6,800 | 38,692 | 6,800 | 0 to 6.8 K |
Aug 03 2010 | CBIO | CATALYST BIOSCIENC ... | DUNTON ALAN W | Director | Option Exercise | M | 5.69 | 6,000 | 34,140 | 7,000 | |
Aug 03 2010 | CBIO | CATALYST BIOSCIENC ... | DUNTON ALAN W | Director | Sell | S | 22.30 | 6,000 | 133,791 | 0 | 6 K to 0 (-100.00 %) |
Aug 03 2010 | CBIO | CATALYST BIOSCIENC ... | DUNTON ALAN W | Director | Buy | M | 5.69 | 6,000 | 34,140 | 6,000 | 0 to 6 K |
Jun 18 2010 | CBIO | CATALYST BIOSCIENC ... | SNYDERMAN RALPH | Director | Option Exercise | A | 22.76 | 7,500 | 170,700 | 7,500 | |
Jun 18 2010 | CBIO | CATALYST BIOSCIENC ... | SKALETSKY MARK B | Director | Option Exercise | A | 22.76 | 12,500 | 284,500 | 12,500 | |
Jun 18 2010 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Option Exercise | A | 22.76 | 7,500 | 170,700 | 7,500 | |
Jun 18 2010 | CBIO | CATALYST BIOSCIENC ... | DESOUZA ERROL B | Director | Option Exercise | A | 22.76 | 7,500 | 170,700 | 7,500 | |
Jun 18 2010 | CBIO | CATALYST BIOSCIENC ... | DUNTON ALAN W | Director | Option Exercise | A | 22.76 | 7,500 | 170,700 | 7,500 | |
Jun 18 2010 | CBIO | CATALYST BIOSCIENC ... | BURRILL STEVEN | Director | Option Exercise | A | 22.76 | 7,500 | 170,700 | 7,500 | |
Jun 18 2010 | CBIO | CATALYST BIOSCIENC ... | BROWN JULIA R | Director | Option Exercise | A | 22.76 | 7,500 | 170,700 | 7,500 | |
Jun 17 2010 | CBIO | CATALYST BIOSCIENC ... | BARRETT M JAMES | Director | Option Exercise | A | 22.76 | 7,500 | 170,700 | 7,500 | |
Jun 18 2010 | CBIO | CATALYST BIOSCIENC ... | BLIXT CHARLES A | Director | Option Exercise | A | 22.76 | 7,500 | 170,700 | 7,500 | |
May 24 2010 | CBIO | CATALYST BIOSCIENC ... | BROWN JULIA R | Director | Option Exercise | M | 8.70 | 7,307 | 63,571 | 12,500 | |
May 24 2010 | CBIO | CATALYST BIOSCIENC ... | BROWN JULIA R | Director | Option Exercise | M | 8.70 | 5,193 | 45,179 | 19,807 | |
May 24 2010 | CBIO | CATALYST BIOSCIENC ... | BROWN JULIA R | Director | Sell | S | 23.13 | 7,307 | 169,018 | 0 | 7.3 K to 0 (-100.00 %) |
May 24 2010 | CBIO | CATALYST BIOSCIENC ... | BROWN JULIA R | Director | Buy | M | 8.70 | 7,307 | 63,571 | 7,307 | 0 to 7.3 K |
May 24 2010 | CBIO | CATALYST BIOSCIENC ... | BROWN JULIA R | Director | Sell | S | 22.97 | 5,193 | 119,278 | 0 | 5.2 K to 0 (-100.00 %) |
May 24 2010 | CBIO | CATALYST BIOSCIENC ... | BROWN JULIA R | Director | Buy | M | 8.70 | 5,193 | 45,179 | 5,193 | 0 to 5.2 K |
May 17 2010 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Option Exercise | M | 5.55 | 1,469 | 8,153 | 10,531 | |
May 17 2010 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Sell | S | 25.00 | 1,469 | 36,725 | 0 | 1.5 K to 0 (-100.00 %) |
May 17 2010 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Buy | M | 5.55 | 1,469 | 8,153 | 1,469 | 0 to 1.5 K |
May 17 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 1,494 | 2,615 | 7,349 | |
May 17 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 25.00 | 1,494 | 37,350 | 1,153 | 2.6 K to 1.2 K (-56.44 %) |
May 17 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 1.75 | 1,494 | 2,615 | 2,647 | 1.2 K to 2.6 K (+129.58 %) |
May 19 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Option Exercise | M | 2.93 | 3,424 | 10,032 | 48,694 | |
May 19 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Option Exercise | M | 2.93 | 382 | 1,119 | 52,118 | |
May 19 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Option Exercise | M | 5.10 | 2,408 | 12,281 | 8,789 | |
May 19 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Option Exercise | M | 5.10 | 5,100 | 26,010 | 1 | |
May 19 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Option Exercise | M | 5.10 | 892 | 4,549 | 0 | |
May 19 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Sell | S | 24.70 | 3,424 | 84,572 | 2,799 | 6.2 K to 2.8 K (-55.02 %) |
May 19 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Buy | M | 2.93 | 3,424 | 10,032 | 6,223 | 2.8 K to 6.2 K (+122.33 %) |
May 19 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Sell | S | 24.60 | 382 | 9,397 | 2,799 | 3.2 K to 2.8 K (-12.01 %) |
May 19 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Buy | M | 2.93 | 382 | 1,119 | 3,181 | 2.8 K to 3.2 K (+13.65 %) |
May 19 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Sell | S | 24.21 | 8,400 | 203,348 | 2,799 | 11.2 K to 2.8 K (-75.01 %) |
May 19 2010 | CBIO | CATALYST BIOSCIENC ... | Musso Alan A | SVP, CFO & Treasure ... | Buy | M | 5.10 | 8,400 | 42,840 | 11,199 | 2.8 K to 11.2 K (+300.11 %) |
May 18 2010 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Option Exercise | M | 7.10 | 7,500 | 53,250 | 0 | |
May 18 2010 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Option Exercise | M | 0.08 | 1,000 | 75 | 0 | |
May 18 2010 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Sell | S | 24.22 | 8,500 | 205,863 | 5,333 | 13.8 K to 5.3 K (-61.45 %) |
May 18 2010 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Buy | M | 7.10 | 7,500 | 53,250 | 13,833 | 6.3 K to 13.8 K (+118.43 %) |
May 18 2010 | CBIO | CATALYST BIOSCIENC ... | Richard John P | Director | Buy | M | 0.08 | 1,000 | 75 | 6,333 | 5.3 K to 6.3 K (+18.75 %) |
May 17 2010 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Finance & Contro ... | Option Exercise | M | 8.51 | 1,402 | 11,931 | 31,290 | |
May 17 2010 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Finance & Contro ... | Sell | S | 25.00 | 1,402 | 35,050 | 1,159 | 2.6 K to 1.2 K (-54.74 %) |
May 17 2010 | CBIO | CATALYST BIOSCIENC ... | Hodges Mauri K | VP Finance & Contro ... | Buy | M | 8.51 | 1,402 | 11,931 | 2,561 | 1.2 K to 2.6 K (+120.97 %) |
May 14 2010 | CBIO | CATALYST BIOSCIENC ... | Hicks Karen A | VP Human Resources | Sell | S | 24.10 | 4,226 | 101,851 | 0 | 4.2 K to 0 (-100.00 %) |
May 04 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | M | 8.51 | 14,278 | 121,506 | 42,832 | |
May 04 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | M | 5.55 | 2,722 | 15,107 | 21,547 | |
May 04 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | M | 5.55 | 15,263 | 84,710 | 24,269 | |
May 04 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Sell | S | 24.29 | 17,000 | 412,848 | 7,735 | 24.7 K to 7.7 K (-68.73 %) |
May 04 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Buy | M | 8.51 | 14,278 | 121,506 | 24,735 | 10.5 K to 24.7 K (+136.54 %) |
May 04 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Buy | M | 5.55 | 2,722 | 15,107 | 10,457 | 7.7 K to 10.5 K (+35.19 %) |
May 04 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Sell | S | 24.27 | 15,263 | 370,506 | 7,735 | 23 K to 7.7 K (-66.37 %) |
May 04 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Buy | M | 5.55 | 15,263 | 84,710 | 22,998 | 7.7 K to 23 K (+197.32 %) |
May 13 2010 | CBIO | CATALYST BIOSCIENC ... | BROWN JULIA R | Director | Sell | S | 23.05 | 7,500 | 172,875 | 0 | 7.5 K to 0 (-100.00 %) |
Apr 30 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | M | 5.55 | 22,015 | 122,183 | 39,532 | |
Apr 30 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | M | 1.75 | 13,085 | 22,899 | 12,000 | |
Apr 30 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Option Exercise | M | 1.75 | 16,000 | 28,000 | 25,085 | |
Apr 30 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Sell | S | 24.18 | 35,100 | 848,764 | 7,735 | 42.8 K to 7.7 K (-81.94 %) |
Apr 30 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Buy | M | 5.55 | 22,015 | 122,183 | 42,835 | 20.8 K to 42.8 K (+105.74 %) |
Apr 30 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Buy | M | 1.75 | 13,085 | 22,899 | 20,820 | 7.7 K to 20.8 K (+169.17 %) |
Apr 30 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Sell | S | 24.00 | 16,000 | 384,000 | 7,735 | 23.7 K to 7.7 K (-67.41 %) |
Apr 30 2010 | CBIO | CATALYST BIOSCIENC ... | Caldwell William S | SVP - Drug Discover ... | Buy | M | 1.75 | 16,000 | 28,000 | 23,735 | 7.7 K to 23.7 K (+206.85 %) |
Apr 30 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 14,700 | 25,725 | 8,843 | |
Apr 30 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 24.00 | 14,700 | 352,800 | 1,153 | 15.9 K to 1.2 K (-92.73 %) |
Apr 30 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 1.75 | 14,700 | 25,725 | 15,853 | 1.2 K to 15.9 K (+1,274.93 %) |
Apr 28 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 200 | 350 | 23,543 | |
Apr 28 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Option Exercise | M | 1.75 | 257 | 450 | 23,743 | |
Apr 28 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Sell | S | 24.00 | 200 | 4,800 | 1,153 | 1.4 K to 1.2 K (-14.78 %) |
Apr 28 2010 | CBIO | CATALYST BIOSCIENC ... | Dunbar Geoffrey C | SVP, Clin. Dev. & R ... | Buy | M | 1.75 | 200 | 350 | 1,353 | 1.2 K to 1.4 K (+17.35 %) |